
Sarepta Therapeutics
The Leader in RNA-based Medicine | Sarepta Therapeutics.
Market cap
$1.8b
Enterprise value
$2.3b
Share price
$18.34 SRPT
Recent deals
- Healthcare
Authorizing premium user...
The Leader in RNA-based Medicine | Sarepta Therapeutics.